A.R.T. Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-11,500
Closed -$226K 1416
2019
Q2
$226K Buy
+11,500
New +$234K 0.01% 1060
2017
Q1
Sell
-37,300
Closed -$629K 1409
2016
Q4
$629K Buy
+37,300
New +$622K 0.04% 652
2016
Q1
Sell
-12,154
Closed -$147K 1333
2015
Q4
$147K Buy
+12,154
New +$150K 0.01% 1279
2015
Q2
Sell
-20,978
Closed -$373K 1462
2015
Q1
$373K Buy
+20,978
New +$390K 0.01% 1027

Other funds holding ANGO

A.R.T. Advisors's ANGO Position: Q3 2019 in Review

A.R.T. Advisors sold out of AngioDynamics (ANGO) in Q3 2019, closing a stake of 11,500 shares — an estimated $226K sold.

A.R.T. Advisors first reported a position in ANGO in Q1 2015 and held it in 4 quarters. The position peaked at $629K in Q4 2016. 173 funds tracked by Wall St. Rank hold ANGO as of Q3 2019.

  • A.R.T. Advisors reported no remaining AngioDynamics position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 11,500 AngioDynamics shares in Q3 2019, an estimated $226K.
  • A.R.T. Advisors first reported a position in AngioDynamics in Q1 2015 and held it in 4 quarters.
  • A.R.T. Advisors's AngioDynamics position peaked at $629K in Q4 2016.
  • 173 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.